When Omega-3 Research Gets Specific

A resistance training study does not redefine omega-3 supplementation. It does something more useful. It demonstrates how clarity in population selection changes what a result means — and how easily that clarity is lost by the time a finding reaches a product label.

Why specificity is the finding

Most omega-3 trials recruit broadly and report an average. That is a reasonable way to establish safety and a rough effect size, but a poor way to answer the question a formulator actually has, which is nearly always: for whom, at what dose, in what form, and measured how?

The interesting result is rarely whether omega-3 works. It is the conditions under which the measurement holds.

What this means for testing

From an analytical standpoint the implication is straightforward. If a study distinguishes between EPA and DHA effects, or between triglyceride and ethyl ester forms, the certificate of analysis behind the product needs to make the same distinctions. A total omega-3 number does not.

• Report EPA, DHA and DPA separately, not as a combined omega-3 figure.
• State the chemical form, because bioavailability differs between them.
• Pair potency with oxidation status — a high EPA number on a rancid oil is not a good result.